11
total announcements
539230.BO · 15 min delayed
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has announced the closure of its trading window for insiders from October 1, 2026, until 48 hours after the announcement of its un-audited financial results for the half year ended September 30, 2026.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has published a newspaper advertisement for its 40th Annual General Meeting (AGM) to be held on September 30, 2026, at its registered office. The company has also provided remote e-voting and e-voting facilities to its members.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has sent a letter to shareholders who have not registered their email address, providing a weblink to the Annual Report for FY 2025-26. The company has also announced its 40th Annual General Meeting (AGM) on September 30, 2026, and reminded shareholders to update their KYC details and dematerialize physical securities.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has announced its Annual Report for FY 2025-26, along with the notice for its 40th Annual General Meeting (AGM) to be held on September 30, 2026. The AGM will consider the financial statements for FY 2025-26, reappointment of a director, and approval of related party transactions.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has announced the 40th Annual General Meeting (AGM) to be held on September 30, 2026, at 11:00 am. The meeting will consider the reappointment of Mr. Rushabh Mehta as director, approval of related party transactions, and increase in authorized share capital.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has published unaudited financial results for the quarter ended 30th June 2026 in compliance with SEBI regulations.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has submitted a corrigendum to rectify a typographical error in the book closure date and Benpose date for the 40th Annual General Meeting. The corrected dates are 24/09/2026 to 30/09/2026 for share transfer book closure and 28/08/2026 for Benpose Date.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has announced its unaudited financial results for the first quarter ended June 30, 2026, and approved several matters, including increasing authorized share capital, issuing unlisted non-convertible redeemable preference shares, and fixing the date for the 40th Annual General Meeting.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has submitted its unaudited financial results for the first quarter ended June 30, 2026. The Board of Directors has approved the results and also considered and approved several other matters, including increasing the authorized share capital, adopting a new set of Articles of Association, and issuing unlisted non-convertible cumulative redeemable preference shares (NCRPS) on a private placement basis.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd's board meeting outcome: approved un-audited financial results for Q2 2026, increased authorized share capital, and issued unlisted non-convertible redeemable preference shares (NCRPS) on a private placement basis.
Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd has scheduled a Board Meeting on 12/08/2026 to consider and approve standalone unaudited financial results for the quarter ended 30th June, 2026.